11/09/2025
🫀𝐌𝐘𝐋𝐈𝐕𝐄 𝟐𝟎𝟐𝟓 𝐚𝐭 𝐊𝐋𝐂𝐂 𝐂𝐨𝐧𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐂𝐞𝐧𝐭𝐫𝐞 🫀
The 21st Malaysian Cardiovascular Interventional Symposium (MYLIVE 2025), held at the Kuala Lumpur Convention Centre from 11–13 September 2025, brings together the region’s top cardiologists, healthcare professionals, and leading brands in interventional cardiology. With live case transmissions from Hospital Sultan Idris Shah Serdang, this year’s theme — Motivation and Innovation in Interventional Cardiology at the Heart of ASEAN — highlights the critical role of advanced cardiovascular treatment in improving patient outcomes
Throughout the three-day programme, delegates will experience:
❇️ Groundbreaking live sessions covering complex PCI, STEMI, bifurcation, and TAVI procedures.
❇️ Cutting-edge symposiums featuring the latest in imaging, physiology, DCB technology, and structural heart innovations.
❇️ Global expertise from renowned interventionalists across Asia, Europe, and the US.
As one of the 𝐎𝐟𝐟𝐢𝐜𝐢𝐚𝐥 𝐄𝐱𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬, 𝐀𝐯𝐞𝐥𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 & 𝐁𝐢𝐨𝐛𝐚𝐲 𝟑𝟕°𝐂 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 are proud to showcase our contribution in advancing cardiovascular health. Cardiovascular diseases remain Malaysia’s leading cause of death, accounting for nearly one in four mortalities. It is crucial to raise awareness about key risk factors such as hypertension, diabetes, smoking, obesity, and sedentary lifestyles.
By integrating evidence-based supplements, patient-focused solutions, and strong partnerships with healthcare professionals, Avelon Healthcare and Biobay aim to support prevention and long-term management of cardiovascular health. Together, with the medical community and industry leaders present at MYLIVE 2025, we aspire to take the cardiovascular industry in Malaysia — and across ASEAN — to the next level.
